Therapy & Medication Treatment is categorized under Internal Medicine Practitioners in Carmel, NY and active since 2007.
Therapy & Medication Treatment was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Kevin Kerrigan at the company’s single location by writing to 90 Gleneida Avenue, Carmel, New York NY 10512 or by phoning (845) 225-4707. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Therapy & Medication Treatment |
Contact Person: | Kevin Kerrigan |
Address: | 90 Gleneida Avenue, Carmel, New York 10512 |
Phone Number: | (845) 225-4707 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 6219992 |
Share This Business: |
Therapy & Medication Treatment was started in 2007 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kevin Kerrigan for inquiries that concern Therapy & Medication Treatment by calling the company number (845) 225-4707, as your correspondence is most welcome. Additionally, the physical location of the single location of Therapy & Medication Treatment can be found at the coordinates 41.429228,-73.679316 as well as the street address 90 Gleneida Avenue in Carmel, New York 10512.
For its online presence, you may visit Therapy & Medication Treatment’s website at and engage with its social media outlets through on Twitter and on Facebook.